A Binding Contract for Anthrax

See allHide authors and affiliations

Science  12 Jul 2002:
Vol. 297, Issue 5579, pp. 201-202
DOI: 10.1126/science.1074590

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


As the anthrax bioterrorism attacks demonstrated last year, individuals infected with the causative organism, Bacillus anthracis, may still die even after successful antibiotic treatment because of the production of large amounts of the anthrax toxin. In their Perspective, Bull and Parrish discuss new work published elsewhere that identifies an antitoxin antibody that could be used to passively immunize infected individuals and neutralize the anthrax toxin.